Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection.
about
Factors determining human-to-human transmissibility of zoonotic pathogens via contactMiddle East Respiratory Syndrome.Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severityMERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesisDevelopment of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen.Antibody Response and Disease Severity in Healthcare Worker MERS Survivors.Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014.Viral RNA in Blood as Indicator of Severe Outcome in Middle East Respiratory Syndrome Coronavirus Infection.Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China.Vaccines for Emerging Infectious Diseases: lessons from MERS coronavirus and Zika virus.The Use of Xenosurveillance to Detect Human Bacteria, Parasites, and Viruses in Mosquito Bloodmeals.Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.Human Coronavirus-HKU1 Infection Among Adults in Cleveland, Ohio.Vaccines for the prevention against the threat of MERS-CoV.Epidemiologic Parameters of the Middle East Respiratory Syndrome Outbreak in Korea, 2015.Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).MERS-coronavirus: From discovery to intervention.Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses.ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice.Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus.Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus.An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus.Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study.MERS-CoV: Understanding the Latest Human Coronavirus Threat.Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection
P2860
Q28073931-3493E45B-3091-48CC-B2D2-EE582CF57B54Q30274816-E4F1E81D-5B7D-4A7C-9EEE-BA44BEEC93D4Q33431974-AD42DD6B-0384-4971-8139-43659C72FE75Q33908067-B06CCCB7-10CA-4EF2-94DF-8BC1AC7753CEQ36393296-CA34A7D6-937F-4731-968F-7038A2212ED4Q36814211-347E91A9-6E06-4406-ADA1-C2FB0289CF4CQ36935287-A34CBC9E-FEB8-4287-9E7C-40283330041EQ37031480-045DAD00-835A-4A04-A0B2-59EAA7D8D6EEQ37288095-4846DF51-B528-4552-A510-D9C2C86C6844Q37489898-05369510-4BD4-4935-90F5-4B6D100EA13EQ38156536-9A9D8CD3-6D05-4A12-B376-1510C17F8279Q38157620-898A1D93-FD1D-43F2-BE06-C204BE0AF503Q38684877-621A7BFA-846D-4495-95E9-7635E6D4734AQ38724992-957EF451-723F-4DE4-A454-10F433959C71Q38778044-26D3556C-BD36-4643-B1AD-D51331363C8CQ38840181-E4B8FBEF-B0F3-4E31-AE1F-A38C14FC60C7Q39034541-5FD9142D-4142-4C5D-83AE-7CB421B6EF24Q39374922-5BBCE204-8AB7-4297-B19C-0D33B24D4B22Q40094147-CB6BCE9D-4E57-494F-A40C-12F0FD17D767Q40173497-F6EAAD98-D1CF-4BEB-868D-3AB8E7747C3EQ40428932-3F406432-D7D7-4CDD-9906-D30CC2CB2168Q40688031-55C18A61-F930-4294-A4C3-1090402F07A7Q43628487-6A46F716-68D6-45BC-B11C-668892E54641Q47132991-0E09F7E6-6470-4A94-8B56-AE2D814B39FAQ47607374-B24941B0-978C-46EC-9602-FDCC80FC34D9Q47656792-984FBB8D-B21D-4B35-A678-B2B9C1AEF2A7Q53701486-7352AB8A-36C9-4998-B938-BC58297C7997Q58765534-BD68EE52-82C1-43CD-BD4B-F43440547306
P2860
Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Viral Shedding and Antibody Re ...... yndrome Coronavirus Infection.
@en
type
label
Viral Shedding and Antibody Re ...... yndrome Coronavirus Infection.
@en
prefLabel
Viral Shedding and Antibody Re ...... yndrome Coronavirus Infection.
@en
P2093
P2860
P50
P356
P1476
Viral Shedding and Antibody Re ...... yndrome Coronavirus Infection.
@en
P2093
Abdullah M Assiri
Ali M Albarrak
Benjamin Meyer
Jaffar Al-Tawfiq
Katja Steinhagen
Malak Almasri
Mohamed Elamin Farah
Mohammed M Albarrak
Tabea Binger
P2860
P304
P356
10.1093/CID/CIV951
P407
P50
P577
2015-11-12T00:00:00Z